Mimetic Medicines

Mimetic Medicines develops short lipidated peptidomimetics (SLiPs) designed to disrupt ion channel-scaffold protein complexes in peripheral pain nerves. These SLiPs selectively target nociceptors responsible for neuropathic pain signaling without crossing the blood-brain barrier. This mechanism offers a potentially disease-modifying approach to pain management with improved safety and tolerability compared to current CNS-acting therapies.

Traction 3/10

Miami, United States · HQ

Founded 20234200+ followers

Biotechnology

Updated 6 months ago

Funding

Funding rounds are not available yet.

Founders

2 founders

Arin Bhattacharjee

Professor and Neuroscientist

John Strumbos

Knowledge is my passion

Product

Features

Mimetic Medicines develops short lipidated peptidomimetics (SLiPs) designed to disrupt ion channel-scaffold protein complexes in peripheral pain nerves. These SLiPs selectively target nociceptors responsible for neuropathic pain signaling without crossing the blood-brain barrier. This mechanism offers a potentially disease-modifying approach to pain management with improved safety and tolerability compared to current CNS-acting therapies.